- Trade Names: Copaxone (Teva); Glatopa (Novartis)
- Indications: Multiple sclerosis
- Synonym: copolymer-1
- Class: Immunomodulator
- Half-life: N/A
- Clinically important, potentially hazardous interactions with:
Hemophilus B Vaccine
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of glatiramer in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 08/20/2025
